Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced that the U.S. Patent and Trademark Office has issued a new patent covering its lead investigational therapy, istaroxime, for intravenous ...

To raise crucial awareness, Fiona Loud, policy director at Kidney Care UK, has highlighted three common kidney problems ...

In TODAY.com's Expert Tip of the Day, a cardiologist explains why neglecting your "second heart" can lead to health ...

A large Framingham Heart Study analysis found that adults with poor cardiovascular health scores on the Life’s Essential 8 ...

Thanks to medical advancements, heart attack deaths have dropped nearly 90% in the last 50 years. But deaths from these ...

Cold drink- or food-induced atrial fibrillation/flutter, termed “cold drink heart,” is understudied and underrecognized, but ...

In this high-yield, clinically focused session, Dr. Steven L. Cohn, one of the leading experts in perioperative medicine, ...

Decreases seen in mortality for acute MI, ischemic heart disease, while increases seen for mortality from other heart disease subtypes ...

If istaroxime is approved in the US for acute heart failure, this patent would provide protection to 2039 ...

Treat it like tobacco: avoid criminalizing it, discourage its use, and protect bystanders, says editorial. Cannabis use is ...

The federally funded work led by Johns Hopkins researchers could save many lives and spare many people unnecessary medical ...

A scientific statement has been published by the ACC regarding the management of obesity in adults with heart failure.